Share on StockTwits

CSL Limited (ASX:CSL)‘s stock had its “hold” rating reaffirmed by equities researchers at Deutsche Bank in a research report issued on Sunday. They currently have a $73.20 price objective on the stock.

Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Wednesday. They now have a $74.55 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of A$73.18 ($67.76).

Shares of CSL Limited (ASX:CSL) opened at 70.460 on Friday. CSL Limited has a 1-year low of A$63.500 and a 1-year high of A$72.820. The stock has a 50-day moving average of A$67.09 and a 200-day moving average of A$69.04. The company has a market cap of A$33.992 billion and a price-to-earnings ratio of 26.17.

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.